TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,136.92−0.09%Brent$109.07−0.13%BTC$81,806.54−0.25%ETH$2,403.53−0.16%DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,136.92−0.09%Brent$109.07−0.13%BTC$81,806.54−0.25%ETH$2,403.53−0.16%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralClosed 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralClosed 🇺🇸United StatesNasdaq · NYSE · S&P 500Closed 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Closed

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Abeona Therapeutics Inc · Overview · TradingHolo

Markets › United States › NAS › ABEO

A

Abeona Therapeutics Inc

NAS:ABEOHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$4.41−0.45%At closeAt close · Tue 20 Oct · ≈ AED 16.20 · Market cap $252.18M · Next earnings Wed 11 Nov

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

1D

−0.5%

1M

−20.8%

3M

−31.6%

6M

−19.5%

1Y

−19.9%

Why it's moving today

No company news in the last day; the move tracks its market and sector.

ABEO −0.45% today

✦ This week in three lines

No written digest yet for ABEO. The figures on this page are the source when one is written.

Financials

USD millions · annual5Y CAGR −10.3%

Valuation

P/E vs sector3.6× vs −1.7×

Price / Book vs sector1.6× vs 2.0×

Price / Sales vs sector43.5× vs 3.9×

Price / Free cash flow vs sector−3.0× vs −1.6×

cheap for itself (4.2×)expensive for itself (11.4×)

Forecasts

7 buy0 hold0 sell7 analysts

Average target$18.00 +308.2%

Analysts2

EPS surprises, last 86 beats

Dividends

Yield0.0%

Annual payout—

Payout ratio0.0%

Next ex-date—

Years of growth—

Latest news

All ABEO news →

GLAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire · 18 d ago

BEAbeona Stands to Collect Royalties After Ultragenyx's FDA Approval — Here's the Rest of the Week

benzinga · 32 d ago

GLAbeona Therapeutics® Congratulates Ultragenyx on U.S. FDA Approval of FAYUVI™ Gene Therapy for Sanfilippo Syndrome Type A (MPS IIIA)

globenewswire · 32 d ago

Key facts

At close · Tue 20 Oct

Market cap (USD)$252.18M

P/E3.6×

Dividend yield0.0%

52-week range$4.00 – $7.65

Avg volume (20d)1,196,636

Shares outstanding57,184,000

Beta1.34

Short interest33.3% of float

Next earningsWed 11 Nov

Radar Score

50

Value51

Quality67

Momentum38

Income45

Peer percentile within United States Healthcare0–100 · null when more than one input is missing

About

Abeona Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, focused on creating innovative gene and cell therapies to address severe and uncommon genetic diseases. Its leading program, EB-101, an autologous gene-corrected cell therapy, is presently in a Phase III clinical trial for…

SectorHealthcare

IndustryNormal

ExchangeNAS

Peers

LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE

56.6×−1.33%

JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE

22.8×−0.69%

ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE

118.2×−0.96%

UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE

30.3×+1.36%